Gossamer Bio
The Director of Forecasting Analytics will lead development and management of robust forecasting capabilities to support the launch and commercialization of Gossamer Bio’s first rare disease therapy. The role partners across Market Insights, Commercial, Finance, Supply Chain, and Corporate Strategy to deliver accurate, data-driven forecasts that inform strategic and operational decisions. The position requires establishing forecasting tools, governance, and processes and integrating real-world and research insights as the organization scales.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2017
Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development of seralutinib, an investigational inhaled PDGFRα/β, CSF1R, and c-KIT inhibitor delivered via dry powder inhaler, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company's lead program is currently being evaluated in the PROSERA Study, a Phase 3 clinical trial in adults with PAH. Gossamer Bio is committed to improving the lives of patients with these rare diseases.
Gossamer lung disease drug fails late-stage study, but company will still seek FDA approval
2 weeks ago
Gossamer Bio shares plummet as lung disease drug fails late-stage trial
2 weeks ago
GOSS Investors Have Opportunity to Join Gossamer Bio, Inc. Fraud Investigation with the Schall Law Firm
1 week ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Gossamer Bio.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS
2 days ago
Senior Manager of Forecasting & Analytics
Veradermics
Senior Manager, Forecasting
Alfasigma
CD&A - Senior Director, US Forecasting, Rare Disease
Amgen
Director, US and Global Forecasting and Analytics - Infectious Disease (ID)
AstraZeneca
Commercial Forecasting
GSK plc
Associate Director, Forecasting & Analytics Biosimilars
1080030P